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1. Introduction {#sec1}
===============

Nowadays, our fast-moving, interdependent and interconnected world offers countless new opportunities for the spread of infectious diseases. From a geographical point of view, the speed of today\'s infectious diseases is faster than any time in history. Among them, tuberculosis (TB) has been one of the major threats in the world, and is difficult to be controlled for its easy infection. While under this situation, drug-resistant TB began to appear and showed an upward trend. The main reason is that those patients with vulnerable touches of mycobacterium TB may develop multidrug resistance TB due to inadequate treatment courses, not take medicine with a doctor\'s instructions or inferior quality medicine in the treatment process ([@bib17]). However, drug-resistant strains of TB variant caused by patient\'s forgetting to take medicine or terminating of treatment prior to the completion of a treatment cycle, may develop different levels of drug-resistance to those medications for treatment ([@bib6]; [@bib15]). Drug-resistant TB has a higher mortality rate, among them, multi-drug resistant tuberculosis (MDR-TB) is more prominent, and has become another new serious problem ([@bib14]).

According to the world health organization (WHO) global TB report in 2017, it is estimated that there will be 490,000 new cases of MDR-TB in 2016, in addition, 110,000 new patients who resistant to rifampicin meet the treatment conditions of multi drug resistance tuberculosis. India, China and the Russian federation together account for 47 per cent of the two (about 0.6 million cases). However, 600, 000 patients with MDR-TB in this study, only 129,000 (22 per cent) were enrolled for treatment. There is a gap between the incidence of drug-resistant TB and the number of received treatment cases, ten countries[1](#fn1){ref-type="fn"} accounted for 75 per cent, while India and China accounted for 39 per cent ([@bib11]).

Drug-resistant TB is a public health issue, which is serious and has attached deeply concern in many developing countries, as well as around the world, it also requires extending the period of treatment, and needs more expensive new drugs. The long-term threat of drug-resistant TB also reminds national health organizations around the world that they need to pay more attention to the research on their pathological mechanisms, infection laws and prevention as well as control measures. With the development of pharmacology, medicine and other research, e.g the study of genetics and bacteriology, there has been a certain degree of cognition of TB. However, due to the complexity of the anti-drug mechanism of TB, there is also no clear explanation for it ([@bib24]). Different researchers in the world have tried to study TB through many factors such as population, behavior habits, ecological environment, social environment and so on. Souza WV et al. ([@bib21]) studied the influence of population behavior. Fan YD et al. ([@bib9]) analyzed the drug resistance under different age structures. Chan-yeung et al. ([@bib7]) studied the drug resistance from the perspective of sociology.

Mathematical modeling is a very important tool to study epidemics, is also used to predict the spread of infectious diseases, and it enables public health policy makers to optimize the use of limited resources as well as to formulate policies effectively for specific populations. Waaler H et al. ([@bib23]) first proposed the mathematical model of TB in 1962. Brogger S ([@bib3]) proposed a non-complete linear infection rate in 1967 and perfected the model. Castillo-Chavez et al. ([@bib5]) proposed the basic SEIR model for the spread of TB\'s study in 1997. Ronoh M et al. ([@bib19]) extend the standard SEIRS epidemiology model of TB to include MDR-TB. Blower SM et al. ([@bib2]) and Rodrigues P et al. ([@bib18]) increase the influence of drug-resistant factors respectively, and study the infection laws of drug-resistant TB. Liu YQ et al. ([@bib13]) describe a novel model combines MDR-TB with undetected TB cases, and the basic reproduction number $R_{\text{0}}$ is calculated. Mishra BK et al. ([@bib16]) propose a mathematical model with an assumption for the transfer of proportion of susceptible population to the vaccination class is considered. Quarantine class is also considered in epidemic model for multidrug-resistant patients, and it is observed that it may play a vital role in controlling the disease. Trauer JM et al. ([@bib22]) present a ten-compartment deterministic model captures many of the observed phenomena important to disease dynamics, including partial and temporary vaccine efficacy, declining risk of active disease following infection, the possibility of reinfection both during the infection latent period and after treatment, MDR-TB and de novo resistance during treatment. Agusto FB et al. ([@bib1]) present a deterministic model with isolation and lost to follow-up for the transmission dynamics of three strains of Mycobacterium TB. Kendall EA et al. ([@bib12]) developed a dynamic transmission model of multi-strain TB epidemics in hypothetical populations reflective of the epidemiological situations. Sharma A et al. ([@bib20]) calibrated a compartmental model to data from drug resistance surveys and WHO TB reports to forecast estimates of incident MDR and XDR TB and the percentage of incident MDR-TB caused by acquired drug resistance. Fofana MO et al. ([@bib10]) used a multistrain model of mycobacterium TB transmission in Southeast Asia to investigate how this practice might facilitate the emergence of extensive drug resistance, i.e., resistance to multiple core agents, and calibrated this model to regional TB and drug resistance data using an approximate Bayesian computational approach. Carvalho ARM et al. ([@bib4]) studied the impact of diabetes and MDR strains in a non-integer order model for TB infection in a community.

Mathematical epidemiology has contributed a lot to the understanding of disease transmission processes and their control, but the specifics are still unknown. In the present work, we extend the standard SEIS mathematical model to take into account the MDR-TB. We assume that drug resistance can emerge by infection or as a consequence of treatment (not proper treated for various reasons). The feasible region, equilibrium points and stability of this model are analyzed, the numerical simulations are performed to predict the development of the epidemic situation.

2. Model and method {#sec2}
===================

2.1. Model {#sec2.1}
----------

The mechanism of the dynamical transfer of the disease through the total population is depicted in [Fig. 1](#fig1){ref-type="fig"}, where $S$ is the susceptible, $E_{s}$ is the exposed of general TB, $E_{r}$ is the exposed of MDR-TB, $I_{s}$ is the infected of general TB, $I_{r}$ is the infected of MDR-TB.Fig. 1The modified transfer diagram of the SEIS model.Fig. 1

Where $b$ is natural birth rate. $d$ is natural mortality. $\alpha$ is the death rate induced by disease. $\beta$ is the coefficient indicating the rate at which new infections arise given contacts between susceptible and infectious individuals. $\gamma$ is the cure rate of the infected humans. $t_{\gamma}$ is the transformation rate from the infected with drug-sensitive strains to drug-resistant strains. All parameters are non-negative. Logistic model is employed to describe the population variation to time$$\frac{dN}{dt} = \left( {b - d} \right)\left( {1 - \frac{N}{k}} \right)N - \alpha\left( {I_{s} + I_{r}} \right)$$

Therefore, $bN - mN^{2}$ refers to the recruitment of susceptible individuals into the population by birth or by immigration, where $m = \left( {b - \alpha} \right)/k$, *k* is the environmental capacity.

According to the normal condition, we assume $b - d > 0$. It can be infer that when $N > k$, $\frac{dN}{dt} < 0$, then the final tread of entire trajectories of this equation are tend, enter or stay in$N = S + E_{s} + E_{\gamma} + I_{s} + I_{\gamma} \leq k$. Therefore, the feasible region of this equation is$$\Gamma = \left\{ {\left( {S,E_{s},E_{\gamma},I_{s},I_{\gamma}} \right) \in R^{5}} \right.,0 \leq S,E_{s},E_{\gamma},I_{s},I_{\gamma} \leq k,0 \leq S + E_{s} + E_{\gamma} + I_{s} + I_{\gamma} \leq \left. k \right\}\text{.}$$

This model adopts bilinear incidence and follows system of ordinary differential equations$$\left\{ \begin{array}{l}
{\frac{dS}{dt} = bN - mN^{2} - \beta SI_{s} - \beta SI_{\gamma} + \gamma I_{s} + \gamma I_{\gamma} - d \cdot S} \\
{\frac{dE_{s}}{dt} = \beta SI_{s} - \beta E_{s}I_{\gamma} - \left( {\omega + d} \right)E_{s}} \\
{\frac{dE_{\gamma}}{dt} = \beta SI_{\gamma} + \beta E_{s}I_{\gamma} - \left( {\omega + d} \right)E_{\gamma}} \\
{\frac{dI_{s}}{dt} = \omega E_{s} - \left( {\gamma + \alpha + d + t_{\gamma}} \right)I_{s}} \\
{\frac{dI_{\gamma}}{dt} = \omega E_{\gamma} + t_{\gamma}I_{s} - \left( {\gamma + \alpha + d} \right)I_{\gamma}} \\
\end{array} \right.$$

2.2. Reproduction number $R_{\text{0}}$ {#sec2.2}
---------------------------------------

Let $x = \left( {S,E_{s},E_{\gamma},I_{s},I_{\gamma}} \right)^{T}$, divided *x* into 2 parts, *x*~1~ = (*S*, *E*~s~, *I*~s~)^T^, *x*~2~=(*S*, *E*~r~, *I*~r~) ^T^. The infected compartments are *E* and *I*, giving *m* = 2. Following the method of next generation matrix by P.van den Driessche and Watmough ([@bib8]), we derive the reproduction number of TB ($R_{1}$) and MDR TB ($R_{2}$), respectively.$$f_{1} = \left\lbrack \begin{array}{l}
{\beta SI_{s}} \\
{\ \ \text{0}} \\
{\ \ \text{0}} \\
\end{array} \right\rbrack,\mspace{9mu} v_{1} = \left\lbrack \begin{array}{l}
{\beta E_{s}I_{\gamma} + \left( {w + d} \right)E_{s}} \\
{\left( {\gamma + \alpha + d + t_{\gamma}} \right)I_{\gamma} - \omega E_{s}} \\
{- bN + mN^{2} + \beta SI_{\gamma} - \gamma I_{s} - \gamma I_{\gamma} + dS} \\
\end{array} \right\rbrack\text{.}$$

It's easy to get$${F_{1}}^{'} = \begin{bmatrix}
0 & {\beta S_{0}} \\
0 & 0 \\
\end{bmatrix},\mspace{9mu}{V_{1}}^{'} = \begin{bmatrix}
{\omega + d} & 0 \\
{- \omega} & {\gamma + \alpha + d + t_{\gamma}} \\
\end{bmatrix}\text{,}$$$${F_{1}}^{'}{V_{1}}^{' -} = \begin{bmatrix}
\frac{\beta S_{0}\omega}{\left( {\omega + d} \right)\left( {\gamma + \alpha + d + t_{\gamma}} \right)} & \frac{\beta S_{0}}{\gamma + \alpha + d + t_{\gamma}} \\
0 & 0 \\
\end{bmatrix}\text{.}$$

Therefore,$$R_{1} = \rho\left( {{F_{1}}^{'}{V_{1}}^{' -}} \right) = \frac{\beta\omega S_{0}}{\left( {\omega + d} \right)\left( {\gamma + \alpha + d + t_{\gamma}} \right)}$$

Similarly,$$f_{2} = \begin{bmatrix}
{\beta SI_{\gamma} + \beta E_{s}I_{\gamma}} \\
0 \\
0 \\
\end{bmatrix},\mspace{9mu} v_{2} = \begin{bmatrix}
{\left( {w + d} \right)E_{\gamma}} \\
{\left( {\gamma + \alpha + d} \right)I_{\gamma} - \omega E_{\gamma} - t_{\gamma}I_{s}} \\
{- bN + mN^{2} + \beta SI_{\gamma} - \gamma I_{s} - \gamma I_{\gamma} + dS} \\
\end{bmatrix}\text{.}$$

Then,$${F_{2}}^{'} = \begin{bmatrix}
0 & {\beta S_{0}} \\
0 & 0 \\
\end{bmatrix},\mspace{9mu}{V_{2}}^{'} = \begin{bmatrix}
{\omega + d} & 0 \\
{- \omega} & {\gamma + \alpha + d} \\
\end{bmatrix}\text{,}$$$${F_{2}}^{'}{V_{2}}^{' -} = \begin{bmatrix}
\frac{\beta S_{0}\omega}{\left( {\omega + d} \right)\left( {\gamma + \alpha + d} \right)} & \frac{\beta S_{0}}{\gamma + \alpha + d} \\
0 & 0 \\
\end{bmatrix}\text{.}$$

Therefore,$$R_{2} = \rho\left( {{F_{2}}^{'}{V_{2}}^{' -}} \right) = \frac{\beta\omega S_{0}}{\left( {\omega + d} \right)\left( {\gamma + \alpha + d} \right)}$$

Then, the basic reproduction number$$R_{0} = \max\left\{ {R_{1},R_{2}} \right\} = \max\left\{ {\frac{\beta\omega S_{0}}{\left( \omega + d \right)\left( \gamma + \alpha + d + t_{\gamma} \right)},\frac{\beta\omega S_{0}}{\left( \omega + d \right)\left( \gamma + \alpha + d \right)}} \right\}$$

Because $t_{\gamma} > 0$, then$$R_{0} = \max\left\{ {R_{1},R_{2}} \right\} = R_{2} = \frac{\beta\omega S_{0}}{\left( \omega + d \right)\left( \gamma + \alpha + d \right)}$$

Though the MDR-TB population is much less than the TB (5% or so), it\'s the MDR-TB basic reproduction number *R*~2~ that determines whether TB can invade the population.

2.3. Stability analysis {#sec2.3}
-----------------------

Put $N = S + E_{s} + E_{\gamma} + I_{s} + I_{\gamma}$ into Eq. [(2)](#fd2){ref-type="disp-formula"}, we get$$\left\{ \begin{array}{l}
{\frac{dN}{dt} = \left( {b - d} \right)N - mN^{2} - \alpha\left( {I_{s} + I_{\gamma}} \right)} \\
{\frac{dE_{s}}{dt} = \beta\left( {N - E_{s} - E_{\gamma} - I_{s} - I_{\gamma}} \right)I_{s} - \beta E_{s}I_{\gamma} - \left( {\omega + d} \right)E_{s}} \\
{\frac{dE_{\gamma}}{dt} = \beta\left( {N - E_{s} - E_{\gamma} - I_{s} - I_{\gamma}} \right)I_{\gamma} + \beta E_{s}I_{\gamma} - \left( {\omega + d} \right)E_{\gamma}} \\
{\frac{dI_{s}}{dt} = \omega E_{s} - \left( {\gamma + \alpha + d + t_{\gamma}} \right)I_{s}} \\
{\frac{dI_{\gamma}}{dt} = \omega E_{\gamma} + t_{\gamma}I_{s} - \left( {\gamma + \alpha + d} \right)I_{\gamma}} \\
\end{array} \right.$$

We obtain the equilibrium points for the system of Eq. [(7)](#fd7){ref-type="disp-formula"} by equating each of the equations to 0 as shown below, that is $\frac{d}{dt} = 0$, then$$\left\{ \begin{array}{l}
{\left( {b - d} \right)N - mN^{2} - \alpha\left( {I_{s} + I_{\gamma}} \right) = 0} \\
{\beta\left( {N - E_{s} - E_{\gamma} - I_{s} - I_{\gamma}} \right)I_{s} - \beta E_{s}I_{\gamma} - \left( {\omega + d} \right)E_{s} = 0} \\
{\beta\left( {N - E_{s} - E_{\gamma} - I_{s} - I_{\gamma}} \right)I_{\gamma} + \beta E_{s}I_{\gamma} - \left( {\omega + d} \right)E_{\gamma} = 0} \\
{\omega E_{s} - \left( {\gamma + \alpha + d + t_{\gamma}} \right)I_{s} = 0} \\
{\omega E_{\gamma} + t_{\gamma}I_{s} - \left( {\gamma + \alpha + d} \right)I_{\gamma} = 0} \\
\end{array} \right.$$

The solution of this equation set is the equilibrium point of the system. It is easy to obtain the two equilibrium points of the equation, they are $x_{00} = \left( 0,0,0,0,0 \right)^{T}$ and $x_{01} = \left( {S_{0},0,0,0,0} \right)^{T}$, where $S_{\text{0}}$ is the total population *N*, and $S_{\text{0}}$≤*k*.

The parameters derived from the fifth Chinese TB sample survey in 2010 ([@bib25]) and WHO\'s official statistics on Chinese TB cases from 2010 ([@bib26]) are shown in [Table 1](#tbl1){ref-type="table"}.Table 1Model parameters and values.Table 1ParameterDescriptionValue$\alpha$Death rate induced by disease0.05$b$Natural birth rate0.012$d$Natural mortality0.007$t_{\gamma}$Transformation rate from the TB to MDR-TB0.05*f*TB detection rate0.87$\omega$Removal rate of the exposed to the infected0.18*c*Successfully cure rate0.94$k$Environmental capacity3.6 × 10^9^ ([@bib34])

The cure rate $\gamma$ and the infection rate are determined by TB detection rate *f*,$$\beta = \frac{6 \times \left( {1 - f} \right)}{S}$$$$\gamma = c \ast f$$where *β* means if an infected person is not isolated, it will infect 6 susceptible people in one year.

### 2.3.1. Stability of equilibrium {#sec2.3.1}

According to the model parameters in [Table 1](#tbl1){ref-type="table"}, the two equilibrium points of this model are $x_{00} = \left( 0,0,0,0,0 \right)^{T}$and$x_{01} = \left( {3.6 \times 10^{9},0,0,0,0} \right)^{T}$.

In this paper, the local stability of the equilibrium point depended on the eigen values of Jacobi matrix, which is obtained by linearizing the nonlinear system of the original model at the equilibrium point. If all the real part of eigen values are negative, the solution of this system converges, hence the equilibrium point is locally stable. If the eigen values are zeros, there may be bifurcation phenomenon, which will be further discussed later.

Here, we discuss$x_{00}$ first, the Jacobi matrix at point $x_{00}$ is$$\begin{pmatrix}
{b - d} & 0 & 0 & {- \alpha} & {- \alpha} \\
0 & {- \omega - d} & 0 & 0 & 0 \\
0 & 0 & {- \omega - d} & 0 & 0 \\
0 & \omega & 0 & {- \gamma - \alpha - d - t_{\gamma}} & 0 \\
0 & 0 & \omega & t_{\gamma} & {- \gamma - \alpha - d} \\
\end{pmatrix}\text{.}$$

Then, the corresponding eigen values are$$\left\lbrack {\lambda_{001},\lambda_{002},\lambda_{003},\lambda_{004},\lambda_{005}} \right\rbrack = \left\lbrack {b - d, - \omega - d, - \omega - d, - \gamma - \alpha - d - t_{\gamma}, - \gamma - \alpha - d} \right\rbrack$$

All the parameters except $\lambda_{00}$ are negative, the original equation set is locally asymptotically stable at $x_{00}$ only in the case of $\lambda_{00} < 0$, that is $b - d < 0$ which is not accordant with reality.

Put the parameters of [Table 1](#tbl1){ref-type="table"} into Eq. [(11)](#fd11){ref-type="disp-formula"}, then$$\left\lbrack {\lambda_{001},\lambda_{002},\lambda_{003},\lambda_{004},\lambda_{005}} \right\rbrack = \left\lbrack {0.005, - 0.187, - 0.187, - 0.9248, - 0.8748} \right\rbrack\text{.}$$

Because$\lambda_{001} = 0.005 > 0$, the model is unstable at point $x_{00}$ under this parameter.

Discuss point $x_{01}$ similarly, the Jacobi matrix at point $x_{01}$ is$$\begin{pmatrix}
{d - b} & 0 & 0 & {- \alpha} & {- \alpha} \\
0 & {- \omega - d} & 0 & {\beta k} & 0 \\
0 & 0 & {- \omega - d} & 0 & {\beta k} \\
0 & \omega & 0 & {- \gamma - \alpha - d - t_{\gamma}} & 0 \\
0 & 0 & \omega & t_{\gamma} & {- \gamma - \alpha - d} \\
\end{pmatrix}\text{.}$$

The corresponding eigen values are given by$$\begin{array}{l}
{\lambda_{011} = d - b} \\
{\lambda_{012} = - d - \frac{1}{2}\omega - \frac{1}{2}\gamma - \frac{1}{2}\alpha + \frac{1}{2}\left( {\omega^{2} - 2\gamma\omega - 2\alpha\omega + \gamma^{2} + 2\gamma\alpha + \alpha^{2} + 4\beta\omega k} \right)^{\frac{1}{2}}} \\
{\lambda_{013} = - d - \frac{1}{2}\omega - \frac{1}{2}\gamma - \frac{1}{2}\alpha - \frac{1}{2}\left( {\omega^{2} - 2\gamma\omega - 2\alpha\omega + \gamma^{2} + 2\gamma\alpha + \alpha^{2} + 4\beta\omega k} \right)^{\frac{1}{2}}} \\
{\lambda_{014} = - d - \frac{1}{2}\omega - \frac{1}{2}\gamma - \frac{1}{2}\alpha - \frac{1}{2}t_{\gamma} + \frac{1}{2}\left( \begin{array}{l}
{{t_{\gamma}}^{2} + \omega^{2} - 2\gamma\omega - 2\alpha\omega + \gamma^{2} + 2\gamma\alpha +} \\
{2\gamma t_{\gamma} + \alpha^{2} + 2\alpha t_{\gamma} + 4\beta\omega k} \\
\end{array} \right)^{\frac{1}{2}}} \\
{\lambda_{015} = - d - \frac{1}{2}\omega - \frac{1}{2}\gamma - \frac{1}{2}\alpha - \frac{1}{2}t_{\gamma} - \frac{1}{2}\left( \begin{array}{l}
{{t_{\gamma}}^{2} + \omega^{2} - 2\gamma\omega - 2\alpha\omega + \gamma^{2} + 2\gamma\alpha +} \\
{2\gamma t_{\gamma} + \alpha^{2} + 2\alpha t_{\gamma} + 4\beta\omega k} \\
\end{array} \right)^{\frac{1}{2}}} \\
\end{array}$$

Obviously, $\lambda_{011},\ \lambda_{013},\ \text{and}\ \lambda_{015} < 0$. We find $\lambda_{012} < 0$ as long as $\frac{\beta\omega k}{\left( {\gamma + \alpha + d} \right)\left( {\omega + d} \right)} < 1$, and $\lambda_{014} < 0$ as long as $\frac{\beta\omega k}{\left( \omega + d \right)\left( \gamma + \alpha + d + t_{r} \right)} < 0$. Noticed $R_{1} = \frac{\beta\omega k}{\left( \omega + d \right)\left( \gamma + \alpha + d + t_{r} \right)}$and $R_{2} = \frac{\beta\omega k}{\left( {\gamma + \alpha + d} \right)\left( {\omega + d} \right)}$ respectively, then the equation set is locally asymptotically stable at point $x_{01}$ when $R_{1} < 0$ and $R_{2} < 0$.

Put the parameters of [Table .1](#tbl1){ref-type="table"} into the Jacobi matrix, then obtain the Jacobi matrix of original equation set at point $x_{01}$$$\begin{bmatrix}
{- 0.005} & 0 & 0 & {- 0.05} & {- 0.05} \\
0 & {- 0.187} & 0 & 1.2217 & 0 \\
0 & 0 & {- 0.187} & 0 & 1.2217 \\
0 & 0.18 & 0 & {- 0.9248} & 0 \\
0 & 0 & 0.18 & 0.05 & {- 0.8748} \\
\end{bmatrix}$$

And get the eigen values$$\left\lbrack {\lambda_{011},\ \lambda_{012},\ \lambda_{013},\ \lambda_{014},\ \lambda_{015}} \right\rbrack = \left\lbrack {- 0.005,\  - 1.1526,\  - 1.1124\ ,\ 0.0408,\ 0.0506} \right\rbrack$$

Because$\lambda_{012},\ \lambda_{014} > 0$, this model is unstable at point $x_{01}$ under these parameters.

### 2.3.2. Stability of endemic equilibrium {#sec2.3.2}

There may exist other endemic equilibriums of this equation set in feasible region. By solving the equation set as follows$$\left\{ \begin{array}{l}
{\left( {b - d} \right)N - mN^{2} - \alpha\left( {I_{s} + I_{\gamma}} \right) = 0} \\
{\beta\left( {N - E_{s} - E_{\gamma} - I_{s} - I_{\gamma}} \right)I_{s} - \beta E_{s}I_{\gamma} - \left( {\omega + d} \right)E_{s} = 0} \\
{\beta\left( {N - E_{s} - E_{\gamma} - I_{s} - I_{\gamma}} \right)I_{\gamma} + \beta E_{s}I_{\gamma} - \left( {\omega + d} \right)E_{\gamma} = 0} \\
{\omega E_{s} - \left( {\gamma + \alpha + d + t_{\gamma}} \right)I_{s} = 0} \\
{\omega E_{\gamma} + t_{\gamma}I_{s} - \left( {\gamma + \alpha + d} \right)I_{\gamma} = 0} \\
\end{array} \right.$$

It can be found that there is another endemic equilibrium within the feasible region$$x_{02} = \left( {2.0267 \times 10^{9},\ 0,4.305 \times 10^{8}\text{,}\ 0\ ,8.86 \times 10^{7}} \right)^{T}$$

The Jacobi matrix of the equation set at point $x_{02}$ is$$J = \begin{bmatrix}
J_{11} & J_{12} & J_{13} & J_{14} & J_{15} \\
J_{21} & J_{22} & J_{23} & J_{24} & J_{25} \\
J_{31} & J_{32} & J_{33} & J_{34} & J_{35} \\
J_{41} & J_{42} & J_{43} & J_{44} & J_{45} \\
J_{51} & J_{52} & J_{53} & J_{54} & J_{55} \\
\end{bmatrix}$$where,$$\begin{array}{l}
{J_{11} = b - d - 7043452464m} \\
{J_{14} = J_{15} = - \alpha} \\
{J_{22} = J_{33} = - 9205043\beta - \left( \omega + d \right)} \\
{J_{24} = 1364949290\beta} \\
{J_{31} = 9205043\beta} \\
{J_{34} = - 9205043\beta} \\
{J_{35} = 1355744247\beta} \\
{J_{42} = J_{53} = \omega} \\
{J_{44} = - \gamma - \alpha - d - t_{\gamma}} \\
{J_{55} = - \gamma - \alpha - d} \\
{J_{54} = t_{\gamma}} \\
\end{array}\text{.}$$

The rest values are zero.

By substituting the parameters of [Table 1](#tbl1){ref-type="table"}, we can obtain the Jacobi matrix of this model at point $x_{02}$$$J = \begin{bmatrix}
{- 6.2972 \times 10^{- 4}} & 0 & 0 & {- 0.05} & {- 0.05} \\
0 & {- 0.24041} & 0 & 0.90875 & 0 \\
0.055 & 0 & {- 0.24041} & {- 0.05341} & 0.85534 \\
0 & 0.18 & 0 & {- 0.9248} & 0 \\
0 & 0 & 0.18 & 0.05 & {- 0.8748} \\
\end{bmatrix}$$

The eigen values are given by$$\left\lbrack {\lambda_{021},\ \lambda_{022},\ \lambda_{023},\ \lambda_{024},\ \lambda_{025}} \right\rbrack = \left\lbrack {- 0.0122,\  - 0.0411,\  - 1.0626\ ,\  - 0.0528,\  - 1.1124} \right\rbrack$$

According to the stability theory: when the eigen values are all negative (${Re}\lambda_{i} < 0,\ {Im}\lambda_{i} = 0$), the node is stable. Therefore, $x_{02}$ is stable, namely, the model is locally asymptotically stable at the endemic equilibrium point $x_{02}$ under the parameters of [Table 1](#tbl1){ref-type="table"}.

3. Numerical simulation {#sec3}
=======================

According to the data of the fifth Chinese TB sample survey in 2010 and WHO\'s official statistics on Chinese TB cases in 2010 ([@bib25]; [@bib26]), the initial values for numerical simulation of the MDR-TB dynamics model are shown in [Table 2](#tbl2){ref-type="table"}.Table 2Initial parameters values for numerical simulation.Table 2ParameterDescriptionValue*N*Size of human population1.34 × 10^9^*S*The susceptible1.334 × 10^9^*E*The total exposed (*E*~s~ + *E*~r~)5 × 10^6^*I*The total infected (*I*~s~ + *I*~r~)1.06 × 10^6^*E*~s~The exposed of general TB4.74 × 10^6^*E*~r~The exposed of MDR-TB3 × 10^5^*I*~s~The infected of general TB1 × 10^6^*I*~r~The infected of MDR-TB6 × 10^4^

3.1. TB development trend in future 20 years {#sec3.1}
--------------------------------------------

Based on these data of [Table 2](#tbl2){ref-type="table"}, we studied TB development in China in 20 years since 2010. [Fig. 2](#fig2){ref-type="fig"} is the simulation of TB and MDR TB infective number, red line and blue line represent general TB and MDR-TB respectively, while black line is the total cases of general TB and MDR-TB. It showed the number of infected of general TB has a downward trend, while the number of infected of XDR-TB is always rise in the later 20 years, which proves that MDR-TB\'s control and prevention should be more prominent. Beyond that, the increase in the number of infected of MDR-TB will lead to more exposed and even new infected, the demand for drugs to cure these infected is larger and more time-consuming. In all respects, there are more difficulties in subsequent control and prevention of TB, therefore, it is more important to do it now.Fig. 2Simulation of TB cases in 20 years.Fig. 2

The second column in [Table 3](#tbl3){ref-type="table"} is the statistics of TB cases recorded in WHO\'s official database for the next 8 years since 2010 [@bib27]; [@bib28]; [@bib29]; [@bib30]; [@bib31]; [@bib32].Table 3Number of TB cases in China from 2010 to 2017, by WHO.Table 3yearTB case notificationsThe derived real TB case20177.73 × 10^5^8.89 × 10^5^20167.84 × 10^5^9.01 × 10^5^20158.04 × 10^5^9.24 × 10^5^20148.26 × 10^5^9.49 × 10^5^20138.55 × 10^5^9.83 × 10^5^20129.01 × 10^5^1.04 × 10^6^20119.12 × 10^5^1.05 × 10^6^20109.23 × 10^5^1.06 × 10^6^

. Based on the estimate TB detection rate (87%), the real TB cases derived from WHO TB report are shown in the third column in [Table 3](#tbl3){ref-type="table"}. The trend of the total number of TB cases in 8 years is simulated and compared with the data derived from WHO TB report in [Fig. 3](#fig3){ref-type="fig"}.Fig. 3TB cases from 2010 to 2017.Fig. 3

3.2. Impact of parameters\' variation on numerical simulation {#sec3.2}
-------------------------------------------------------------

The establishment of dynamics model of MDR-TB infection aims at predicting the future outbreaks as well as helping in exploring the best possible preventions and control strategies through numerical simulation, therefore, putting forward some suggestions. In this paper, we consider the effect of detection rate ($f$), transformation rate ($t_{\gamma}$) and successfully cure rate (*c*) on model numerical simulation.

$f$ will affect $\beta$ and $\gamma$ by Eqs. [(9)](#fd9){ref-type="disp-formula"}, [(10)](#fd10){ref-type="disp-formula"}). [Fig. 4](#fig4){ref-type="fig"} showed TB and MDR-TB\'s development under different $f$. It showed $f$ greatly affect the development of TB and MDR-TB. [Fig. 5](#fig5){ref-type="fig"} showed the TB and MDR-TB\'s development under different $t_{\gamma}$. It showed $t_{\gamma}$ also affect the development of MDR-TB. Successfully cure rate coefficient\'s effect is also studied in [Fig. 6](#fig6){ref-type="fig"} which showed it is less than those of $f$ and $t_{\gamma}$.Fig. 4TB and MDR-TB\'s development under different $f$.Fig. 4Fig. 5TB and MDR-TB\'s development under different $t_{\gamma}$.Fig. 5Fig. 6TB and MDR-TB\'s development under different *c*.Fig. 6

4. Discussion {#sec4}
=============

From the simulation results ([Fig. 4](#fig4){ref-type="fig"}), it is easy to find that the increase of *f* will lead to a significant decline in population of the infected in 20 years. It is also showed that *t*~r~ greatly affect the development of MDR-TB. MDR-TB results from either primary infection with resistant bacteria or may develop in the course of a patient\'s treatment. Though *t*~r~ is only 5%, it account for over 70% of the MDR-TB cases after 20 years. Drug resistance arises due to the improper use of antibiotics in chemotherapy of drug-susceptible TB patients. This improper use is a result of a number of actions, including administration of improper treatment regimens by health-care workers and failure to ensure that patients complete the whole course of treatment. Essentially, drug resistance arises in areas with poor TB control programs, therefore, The WHO-recommended treatment strategy for detection and cure of TB is "Directly Observed Treatment, Short-course\" (DOTS) which may prevents the development of MDR-TB by ensuring the full course of treatment is followed ([@bib33]).

DOTS can also increase cure rates up to 95 percent. Obviously, increasing cure rates will help decrease TB cases, but the decrease rate by cure rate is far less than that by detection rate. To a certain extent, the increase in cure rate is far more difficult than that in detection rate, therefore, improving the detection rate *f* is a primary task in the process of TB\'s prevention and control.

5. Conclusion {#sec5}
=============

In the present work, the numerical simulations are performed to predict the development of the epidemic situation. We assume that drug resistance can emerge by infection or as a consequence of treatment (not proper treated for various reasons). In this paper, we extend the standard SEIS mathematical model to take into account the MDR-TB. The feasible region, stability of two equilibriums as well as an endemic equilibrium of this model are analyzed. It is found that the first equilibrium is unstable under the assumption, while the second equilibrium is locally asymptotically stable only at the condition of *R*~1~ \< 0 and *R*~2~ \< 0. With parameters derived from WHO\'s calculation of Chinese TB statistics, we found the equilibrium is unstable, while the endemic equilibrium is stable.

We carried on numerical simulation and analyze the impact of models\' parameters on TB development. The simulation results proved that the key to better prevent and control the spread and develop of TB is to improve the detection rate *f*, and the conversion rate from TB to MDR TB contribute most of the MDR TB cases.
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The treatment cap of drug-resistant TB cases in 10 countries from big to small is: India, China, Russian federation, Indonesia, Philippines, Pakistan, Nigeria, Ukraine, Myanmar and Uzbekistan.
